Last reviewed · How we verify

Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops

St. Joseph's Healthcare Hamilton · FDA-approved active Small molecule Quality 0/100

Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops is a Small molecule drug developed by St. Joseph's Healthcare Hamilton. It is currently FDA-approved. Also known as: FML, Acular, Acuvail, Fluor-Op.

At a glance

Generic nameKetorolac 0.5% and Fluorometholone 0.1% Eye Drops
Also known asFML, Acular, Acuvail, Fluor-Op
SponsorSt. Joseph's Healthcare Hamilton
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops

What is Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops?

Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops is a Small molecule drug developed by St. Joseph's Healthcare Hamilton.

Who makes Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops?

Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops is developed and marketed by St. Joseph's Healthcare Hamilton (see full St. Joseph's Healthcare Hamilton pipeline at /company/st-joseph-s-healthcare-hamilton).

Is Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops also known as anything else?

Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops is also known as FML, Acular, Acuvail, Fluor-Op.

What development phase is Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops in?

Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops is FDA-approved (marketed).

Related